sameAs
Alzheimer's Disease: Mechanism and Approach to Cell TherapyComparison of intraspinal and intrathecal implantation of induced pluripotent stem cell-derived neural precursors for the treatment of spinal cord injury in rats.Human conditionally immortalized neural stem cells improve locomotor function after spinal cord injury in the rat.The role of mesenchymal stromal cells in spinal cord injury, regenerative medicine and possible clinical applications.Complete rat spinal cord transection as a faithful model of spinal cord injury for translational cell transplantationMagnetic resonance tracking of transplanted stem cells in rat brain and spinal cord.In vivo tracking of stem cells in brain and spinal cord injury.Poly(N,N-dimethylacrylamide)-coated maghemite nanoparticles for stem cell labeling.Cyclodextrin-based bimodal fluorescence/MRI contrast agents: an efficient approach to cellular imaging.Highly Efficient Neural Conversion of Human Pluripotent Stem Cells in Adherent and Animal-Free Conditions.Magnetic resonance tracking of transplanted bone marrow and embryonic stem cells labeled by iron oxide nanoparticles in rat brain and spinal cord.The Anti-Inflammatory Compound Curcumin Enhances Locomotor and Sensory Recovery after Spinal Cord Injury in Rats by Immunomodulation.Mesenchymal Stem Cells Preserve Working Memory in the 3xTg-AD Mouse Model of Alzheimer's Disease.Conditionally immortalized stem cell lines from human spinal cord retain regional identity and generate functional V2a interneurons and motorneurons.Green fluorescent protein bone marrow cells express hematopoietic and neural antigens in culture and migrate within the neonatal rat brain.Concise review: reactive astrocytes and stem cells in spinal cord injury: good guys or bad guys?A Comparative Study of Three Different Types of Stem Cells for Treatment of Rat Spinal Cord Injury.Human multipotent mesenchymal stem cells improve healing after collagenase tendon injury in the rat.Beneficial Effect of Human Induced Pluripotent Stem Cell-Derived Neural Precursors in Spinal Cord Injury Repair.hiPSC Disease Modeling of Rare Hereditary Cerebellar Ataxias.Automated tracking of nanoparticle-labeled melanoma cells improves the predictive power of a brain metastasis model.Human induced pluripotent stem cells improve stroke outcome and reduce secondary degeneration in the recipient brain.Analysis of in vitro and in vivo characteristics of human embryonic stem cell-derived neural precursors.Properties and growth of human bone marrow mesenchymal stromal cells cultivated in different media.The use of dopamine-hyaluronate associate-coated maghemite nanoparticles to label cells.The combination of mesenchymal stem cells and a bone scaffold in the treatment of vertebral body defects.Core-shell La(1-x)Sr(x)MnO3 nanoparticles as colloidal mediators for magnetic fluid hyperthermia.Activity-related rise in extracellular potassium concentration in the brain of 1-3-day-old chicks.Imaging the fate of implanted bone marrow stromal cells labeled with superparamagnetic nanoparticles.Hepatocyte growth on polycapronolactone and 2-hydroxyethylmethacrylate nanofiber sheets enhanced by bone marrow-derived mesenchymal stromal cells.Macroporous hydrogels based on 2-hydroxyethyl methacrylate. Part 6: 3D hydrogels with positive and negative surface charges and polyelectrolyte complexes in spinal cord injury repair.Surface modification of hydrogels based on poly(2-hydroxyethyl methacrylate) with extracellular matrix proteins.Acute and delayed implantation of positively charged 2-hydroxyethyl methacrylate scaffolds in spinal cord injury in the rat.Low concentration of isoflurane promotes the development of neurogenic pulmonary edema in spinal cord injured rats.The postischemic environment differentially impacts teratoma or tumor formation after transplantation of human embryonic stem cell-derived neural progenitors.A new model of severe neurogenic pulmonary edema in spinal cord injured rat.Low degree of anesthesia increases the risk of neurogenic pulmonary edema development.Mesenchymal stromal cells prolong the lifespan in a rat model of amyotrophic lateral sclerosis.Flt3 ligand synergizes with granulocyte-colony-stimulating factor in bone marrow mobilization to improve functional outcome after spinal cord injury in the rat.The Effect of Human Mesenchymal Stem Cells Derived from Wharton's Jelly in Spinal Cord Injury Treatment Is Dose-Dependent and Can Be Facilitated by Repeated Application.
P50
Q26778149-1E115174-D338-4338-9DBD-4FE5C0881B5EQ27322391-27D66155-099A-4B14-A3E2-D76D9898784FQ30541296-3C7C3F78-0050-4653-A402-7CBF09A742A6Q30664381-41D787C7-E375-4445-9E11-3968F491F3B7Q30844257-E436F6E4-DE67-45D7-BC0B-9D2ED85A53F4Q31054366-F124FCAD-CFF4-44E7-8698-62DC4D8C04B8Q31118065-1CDBE4BB-0CEA-4ECA-B72D-26940C05C777Q33411844-E3EF244B-921F-4544-BF7D-F96821B7AC52Q33617992-1F054804-07DC-4269-BDC7-EED4605C1187Q33722594-2F8CDAD4-9F8A-4F6A-9021-9668F40C6D88Q34309273-D6D1FF32-989D-469E-B51B-2A720D01CE1EQ36512485-51B7314C-6034-4972-B0FA-A11C9B69E915Q36666929-49718ABB-0894-4367-970B-616217C9CDC0Q36998308-ACBAD5CC-0D8B-4193-83DB-A12FE551ACBEQ37289249-9FF9003C-FF66-4DFD-AFE8-435F88A1633DQ38366449-465FDD68-99E8-4588-BE69-1FD4AB599214Q38726873-EB403179-610F-4024-BD8C-FA55F1C880FBQ38994028-804D2B31-73FD-434B-9AE1-C78B63986EF4Q39122632-6E0A1398-D17E-4306-B5C4-78CEF37A2FB4Q39172573-3A5E8D50-09EB-4390-AC87-17FAE9E01040Q39191693-6A3B0135-4D0A-45E4-AB24-A3A427B38B29Q39298289-4E9F4892-1327-4106-BE96-80C967353F66Q39761510-66F1A528-6E30-4862-A6D8-1C57A9D1CA9FQ39930581-20771533-5487-42B9-A3E0-D323CA02039FQ41982423-D2462D89-DE48-41B2-AA2E-60265A97CE49Q42860698-80BA5DE3-C93D-4A15-B62B-7FF21C7F168AQ42928567-CE7D72E3-D434-4D0F-A573-3FDF5F973B9CQ44602223-9CE6436C-7A9B-4D27-A8AB-EC0F48BDAFB8Q44605764-08F8C9CF-1DF8-49F5-83D7-3D18280B040DQ45289394-CA9FC196-7DF5-46BD-A8CF-EB1067AF684FQ46104156-BB2E2F48-8609-4642-9892-490EA8E00F12Q46227935-1BF5983D-EE6F-45A7-A45C-DE3A132C6D79Q46824686-43B6F81E-659E-441F-9E3D-ED7100BF2130Q46984208-CBB77A4F-1B49-48BB-B0C4-D3621320878FQ48398160-29518A38-9A91-4A48-93BB-907615D6E6B5Q48573568-C950235A-6CBD-4C32-A86A-D7995718320AQ48574928-D4540DDC-1474-4A7F-9AC7-DC03300C0355Q49079226-9FF40F00-9017-49EF-9768-505562F26153Q50538073-4D1ACB64-1EEC-4EE5-AFFB-FB0D3D96E088Q54962427-0C30040F-E2C4-4E6C-9647-F708767D8560
P50
description
Czech researcher
@en
Tsjechisch onderzoekster (1965-)
@nl
investigadora checa
@es
taighdeoir Seiceach
@ga
česká badatelka v oblasti neurověd
@cs
name
Pavla Jendelová
@af
Pavla Jendelová
@an
Pavla Jendelová
@ast
Pavla Jendelová
@bar
Pavla Jendelová
@br
Pavla Jendelová
@bs
Pavla Jendelová
@ca
Pavla Jendelová
@co
Pavla Jendelová
@cs
Pavla Jendelová
@cy
type
label
Pavla Jendelová
@af
Pavla Jendelová
@an
Pavla Jendelová
@ast
Pavla Jendelová
@bar
Pavla Jendelová
@br
Pavla Jendelová
@bs
Pavla Jendelová
@ca
Pavla Jendelová
@co
Pavla Jendelová
@cs
Pavla Jendelová
@cy
altLabel
Pavla Jendelova
@ast
Pavla Jendelova
@en
Pavla Jendelova
@es
Pavla Jendelova
@nl
prefLabel
Pavla Jendelová
@af
Pavla Jendelová
@an
Pavla Jendelová
@ast
Pavla Jendelová
@bar
Pavla Jendelová
@br
Pavla Jendelová
@bs
Pavla Jendelová
@ca
Pavla Jendelová
@co
Pavla Jendelová
@cs
Pavla Jendelová
@cy
P214
P19
P21
P213
0000 0000 5794 1216
P214
P31
P496
0000-0002-4644-9212
P569
1965-08-31T00:00:00Z
P691
P735
P7859
viaf-85749869